Related Experiment Video
Updated: Jun 21, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Functionalized silicon quantum dots tailored for targeted siRNA delivery.
1Department Chemistry and Pharmacy, Physical Chemistry I and ICMM, Friedrich-Alexander University of Erlangen-Nuremberg, Egerlandstrasse 3, Erlangen, Germany.
Biochemical and Biophysical Research Communications
|July 7, 2009
Summary
Researchers developed luminescent silicon quantum dots (SiQDs) as a self-tracking tool for delivering ABCB1 siRNA in Caco-2 cells. This method effectively silenced ABCB1 gene expression and reduced P-glycoprotein function.
Area of Science:
- Biotechnology
- Nanotechnology
- Molecular Biology
Background:
- The ABCB1 gene encodes P-glycoprotein (Pgp), a transporter protein implicated in multidrug resistance.
- Effective delivery of small interfering RNA (siRNA) for gene silencing remains a challenge in cellular research.
- Silicon quantum dots (SiQDs) offer potential as biocompatible nanocarriers due to their unique optical properties.
Purpose of the Study:
- To develop biocompatible luminescent SiQDs for self-tracking delivery of ABCB1 siRNA to Caco-2 cells.
- To investigate the efficacy of SiQD-siRNA complexes in silencing ABCB1 gene expression and Pgp function.
- To monitor the cellular uptake, intracellular trafficking, and siRNA release using advanced imaging and molecular techniques.
Main Methods:
- Synthesis of 2-3nm green-luminescent SiQDs with surface-functionalized 2-vinylpyridine for siRNA binding.
- Complexation of SiQDs with ABCB1 siRNA to form SiQD-siRNA transfection agents.
- Confocal laser scanning microscopy and transmission electron microscopy for visualizing cellular uptake and localization.
- Real-time PCR to quantify ABCB1 mRNA levels and assess gene silencing.
- Time-resolved in situ fluorescence spectroscopy to monitor Pgp efflux activity.
Main Results:
- Successfully developed luminescent SiQDs capable of binding and delivering ABCB1 siRNA to Caco-2 cells.
- Demonstrated efficient cellular uptake and cytoplasmic release of siRNA via SiQD-siRNA complexes.
- Confirmed significant reduction in ABCB1 mRNA levels, indicating successful gene silencing.
- Observed substantially decreased Pgp transporter efficiency for Rhodamine 123 in transfected cells.
Conclusions:
- Biocompatible luminescent SiQDs serve as effective self-tracking nanocarriers for siRNA delivery.
- SiQD-mediated RNA interference successfully down-regulates ABCB1 gene expression and Pgp function in Caco-2 cells.
- This approach provides a promising tool for studying gene function and developing therapeutic strategies involving gene silencing.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.